It presents the latest laparoscopic techniques with figures and illustrations of step-by-step procedures, and offers insight into the potential for novel approaches to treatment in the future. It also includes personal perspectives from patients. Prostate Cancer 2024 pdf epub mobi 电子书 Prostate ...
Prostate Cancer: Diagnosis and Treatment. NICE, London.Frydenberg M, Stricker PD, Kaye KW (1997) Prostate cancer diagnosis and treatment. Lancet 349:1681-1687.Graham J, Baker M, Macbeth F, et al. Prostate Cancer: diagnosis and treatment; 2008. http://www. nice.org.uk/nicemedia/pdf/CG...
Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94 Suppl 3:6.Tunn UW: Advanced prostate cancer treatment guidelines: European perspective. BJU Int 2004, 94(Suppl 3):6.Amling CL. Advanced prostate cancer treatment guidelines: a United States perspective...
To the Editor: In his Editorial, Dr Wilt described the relative lack of reliable evidence for treatment of prostate cancer, and then suggested the need
24, 2024 Neoadjuvant Exercise Therapy in Prostate Cancer JAMA Oncology Research July 18, 2024 Select Your Interests This Issue Citations 134 Download PDF More Cite This Permissions Original Investigation March 8, 2010 Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer Thomas L...
This study aimed to explore the opinions of healthcare professionals regarding the management of men with advanced prostate cancer with particular emphasis on treatment timing and sequencing; treatment adverse-effects and exercise a supportive therapy. S
Nearly one-third of patients with prostate cancer (PCa) experience biochemical recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant metastasis and mortality in patients with prognostically unfavorable features. These patients are best managed with a tailored treatment str...
Health-related quality of life was measured by expanded prostate cancer index composite (EPIC) up to 12 months after treatment. Results: In the sexual domain, RP led to worse summary scores (Po0.001) and more often to a clinically relevant deterioration from baseline than BT and EBRT (79%,...
(EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or in combination with androgen deprivation therapy (ADT) for the treatment of adult men with high-risk biochemical recurrent (BCR) non-metastatic hormone-sensi...
When we detect PIN, allopathy has no treatment for it. Usually, the recommendation is “watchful waiting.” This is prime time for the use of nutrients and herbs to decrease the inflammation that creates PIN and may transform it into full-blown cancer. ...